Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


University of Oxford

UK COVID-19 vaccine is 90% effective using one dosage regimen, trial data suggest

The COVID-19 vaccine being developed by Oxford University is up to 90% effective in preventing COVID-19, interim analysis of trial data suggests. 

flu vaccine

Pharmacy multiples suspend online flu vaccine booking owing to ‘unprecedented demand’Subscription

Three of the UK’s largest pharmacy multiples have suspended online bookings for flu vaccinations owing to high demand.

critical care hospital

Early trial results suggest tocilizumab significantly improves outcomes for critically ill COVID-19 patients

The rheumatoid arthritis drug tocilizumab significantly improves outcomes for critically ill patients with severe COVID-19, early findings from the Randomised, Embedded, Multi-factorial, Adaptive Platform Trial for Community-Acquired Pneumonia have suggested.

pharmacy sign

England has lowest number of community pharmacies in five years, figures showSubscription

Closures in 2019/2020 have resulted in the lowest number of community pharmacies in England since 2015/2016.

Boots logo

Boots in talks with NHS England on COVID-19 vaccination programme

The UK’s largest pharmacy multiple Boots is “in conversations” with NHS England about how it can help provide COVID-19 vaccines to patients, it has said.

nhs england signage

COVID-19 vaccine delivery will need as many community pharmacy vaccinators as possible

Delivery of a COVID-19 vaccine to the public will require the participation of “as many of the workforce who are trained in vaccination as possible” from community pharmacy, an NHS England official has said.

All News


Patients’ perspectives on polypharmacy are highly personal, systematic review concludesSubscription

Healthcare professionals should actively seek to understand individual patients’ perspectives on polypharmacy and its challenges, research in BMJ Open has concluded.

girl with migraine

Fremanezumab safe and effective for preventing migraine over longer term, study suggestsSubscription

Patients with migraine continue to benefit from preventive treatment with fremanezumab over the longer term, with sustained reductions in monthly migraine and headache days, a study in Neurology has suggested.

ibuprofen tablets

Routine NSAID use not associated with poorer outcomes in patients hospitalised with COVID-19

Routine use of non-steroidal anti-inflammatory drugs might confer “modest” survival benefit for patients hospitalised with COVID-19 and is not associated with poorer outcomes, the results of a study published in the Journal of Clinical Medicine have suggested.

Carbapenem resistant bacteria acinetobacter spp

Cefiderocol effective for carbapenem-resistant Gram-negative infectionsSubscription

The clinical and microbiological outcomes of cefiderocol, a new antibiotic, were similar to the best available therapy for patients with life-threatening carbapenem-resistant infections, a phase III study has suggested.

covid 19 cough

Respiratory impairment persists for weeks post-discharge in hospitalised COVID-19 patients

Many patients who contract COVID-19 have detectable lung dysfunction 12 weeks after hospital discharge, results have suggested.

Atopic dermatitis on hands

Addition of baricitinib to mainstay of treatment improves signs and symptoms of atopic dermatitis, study findsSubscription

Adding the oral selective Janus kinase 1 and 2 inhibitor, baricitinib, to topical corticosteroid treatment significantly improves the signs and symptoms of moderate-to-severe atopic dermatitis, a phase III study in JAMA Dermatology has suggested.

All Science